A comprehensive assessment of DPM’s medicine regulatory system was conducted September to October 2017 by SIAPS funded by USAID. The WHO Global Benchmarking Tool was used for data collection. The scope of the assessment was focused on the five regulatory functions: national regulatory systems, medicines registration and marketing authorization (MA), pharmacovigilance (PV), market surveillance and … Read more
Archive S Diarra
Guidance on Elements to Consider when Planning for the Integration of Oxytocin into the EPI Cold Chain
The purpose of this document is to provide guidance to national program managers who are considering integrating oxytocin into the EPI cold chain. It is intended for representatives from relevant offices of the Ministry of Health (MoH), such as Pharmacy, Central Medical Stores, and Maternal and Child Health, as well as other policy makers, stakeholders, and … Read more
Guidance for Planning the Introduction of New Reproductive, Maternal, Newborn, and Child Health Medicines and Supplies
The purpose of this document is to provide guidance to program managers in ministries of health at national and sub-national levels as well as personnel in other interested organizations on actions to take and factors to consider when expanding access to essential RMNCH commodities. While this document focuses on RMNCH medicines and supplies, it may be used as a … Read more
Building Systems for Access and Appropriate Use of iCCM Medicines
Briggs J, Yeager B, Diarra S. Building Systems for Access and Appropriate Use of iCCM Medicines. This seminar was presented as part of the 2016 USAID Global Health Mini-University. For more information on the Mini-University, visit www.mini-university.com.
Ensuring Access to and Appropriate Use of Medicines for iCCM: It takes a system
Briggs J, Joshi MP, Yeager B, Diarra S. Ensuring access to and appropriate use of medicines for iCCM: It takes a system. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA. November 3, 2015.
Étude de faisabilité de l’élargissement de l’accès aux TDR et CTA dans les pharmacies du secteur privé au Mali : Rapport de recherche
La présente étude vise à examiner la faisabilité d’une introduction des tests de diagnostic rapide (TDR) et combinaisons thérapeutiques à base d’artémisinine (CTA) subventionnés pour la prise en charge du paludisme dans les pharmacies du secteur privé au Mali, et déterminer quels éléments doivent être pris en compte afin de garantir que cette introduction s’effectue … Read more
Integration of Oxytocin into the Cold Chain of the Expanded Programme on Immunization: Case of Mali
Postpartum hemorrhage (PPH) still remains one of the major causes of maternal mortality, accounting for 35% of all maternal deaths. The World Health Organization (WHO) has recommended oxytocin as the most effective medicine for the prevention and treatment of PPH, particularly for facility-based births. Most countries include oxytocin on their essential medicines lists (EML) as … Read more
Report on Work to Raise Awareness on the Introduction of 7.1 Percent Chlorhexidine Digluconate for Umbilical Cord Care in the Democratic Republic of the Congo
The Ministry of Health, through the Department for the Health of Families and Specific Groups (D10), organized a workshop on August 29–30, 2013, to sensitize policy makers and operational partners. This resulted in development of the outline for a strategic plan for the introduction and use of 7.1 percent CHX for umbilical cord care in … Read more